U.S. Building Stock News

In early May 2026, Gibraltar Industries reported first-quarter sales of US$356.29 million, up from US$246.36 million a year earlier, but swung from a US$21.12 million profit to a US$67.47 million net loss largely tied to the OmniMax acquisition and discontinued Renewables operations. Despite this loss and margin pressure from commodity inflation and higher interest costs, management reaffirmed full-year 2026 guidance, signaling confidence in OmniMax integration benefits, improving...

Novanta recently announced that it will release its latest quarterly earnings results after the market close on Monday, with the market expecting year-on-year revenue growth of 8.6% following several quarters of revenue and operating income shortfalls versus analyst estimates. At the same time, CEO Matthijs Glastra sold 6,500 shares under a pre-arranged Rule 10b5-1 plan while retaining a significant indirect stake through a 2021 irrevocable trust, underscoring continued insider exposure...

In the first quarter of 2026, Repligen Corporation reported revenue of US$194.26 million and net income of US$8.33 million, both higher than a year earlier, and raised its full-year adjusted earnings guidance while slightly trimming its revenue outlook. These results reflected broad growth across key product lines, early benefits from a margin-focused restructuring program, and the impact of divesting the non-core Polymem filtration business. We’ll now examine how Repligen’s higher...

In the first quarter of 2026, Hecla Mining Company reported sales of US$411.43 million but booked a net loss of US$19.03 million, declared common and preferred dividends, and increased silver production to 3.9 million ounces, about 3% above the prior quarter. The combination of a debt-free balance sheet, record free cash flow from continuing operations, and a renewed focus on silver growth projects marks a significant shift in how Hecla funds expansion and rewards shareholders. With Hecla...

In late April 2026, CareDx, Inc. reported first-quarter 2026 revenue of US$117.7 million and net income of US$2.81 million, alongside basic and diluted earnings per share of US$0.05 from continuing operations, reversing a loss a year earlier. On the same day, CareDx raised its full-year 2026 revenue outlook to a range of US$447 million to US$465 million and filed an omnibus shelf registration, highlighting both improved operating performance and plans to retain flexibility in how it funds...

Assessing recent moves in EquipmentShare.com (EQPT) EquipmentShare.com (EQPT) has caught investor attention after a recent single day gain of 5.8%, extending an 18.5% rise over the past week, even as the stock remains down over the past 3 months and year to date. See our latest analysis for EquipmentShare.com. That sharp 1-day share price return of 5.83%, on top of a 7-day share price return of 18.48%, comes after a tougher stretch where the 90-day share price return declined 36.33% and the...

Recent share performance and business snapshot Hotel101 Global Holdings (HBNB) has been on the radar after a weaker share performance, with the stock down about 10% over the past month and roughly 21% over the past 3 months. The company operates a prop tech hospitality platform that combines advance sales of individual hotel units during construction with recurring revenue from hotel operations. It reports annual revenue of US$75.87 million alongside a net loss of US$26.71 million. See our...

In early May 2026, shareholder advocate John Chevedden submitted a proposal urging Dollar Tree’s board to allow shareholders to act by written consent, while the company responded by filing a definitive proxy statement asking investors to vote against this governance change at its June 16, 2026 annual meeting. This clash over written consent rights comes as Dollar Tree faces execution challenges with its new multi-price strategy, including inventory gaps and inconsistent stock that have...

Expedia Group (EXPE) is back in focus after a packed Q1 2026 update, combining earnings, fresh guidance, a new US$5b buyback plan and a US$0.48 quarterly dividend declaration. See our latest analysis for Expedia Group. Despite a sharp 1 day share price drop of 9.02% and a year to date share price decline of 18.72%, Expedia Group still carries a 1 year total shareholder return of 38.63% and a 3 year total shareholder return of about 15x. This suggests that recent volatility sits against a much...

In April 2026, Park Hotels & Resorts reported first-quarter results showing sales of US$356 million and revenue of US$622 million, with net income of US$11 million compared with a net loss a year earlier. On the same day, the company slightly lowered its full-year 2026 earnings guidance, signaling more cautious expectations despite the return to profitability. We will now examine how Park’s improved quarterly profitability but trimmed full-year earnings outlook could influence the existing...

Centerspace (CSR) drew fresh attention after reporting Q1 2026 results that included lower sales, a wider net loss, and a reaffirmed outlook calling for flat to modest same-store revenue growth this year. See our latest analysis for Centerspace. The stock has had a mixed year, with a 30 day share price return of 5.84% and a 1 year total shareholder return of 16%. This suggests momentum has been building even as Q1 results and the ongoing review keep risks front of mind. If this kind of...

Earlier in May 2026, Everpure announced new Portworx capabilities for Red Hat OpenShift, including Plugin 2.2, Portworx Enterprise 3.6, and Portworx Backup 2.11, aimed at simplifying Kubernetes-native storage, backup, and disaster recovery for AI, container, and virtual machine workloads across hybrid and edge environments. This move deepens Everpure’s integration directly into the OpenShift console, making data management more accessible for enterprises standardizing on Kubernetes for...

In late April 2026, Unum Group reported first-quarter 2026 results showing higher revenue of US$3,355.2 million and net income of US$232 million, alongside completed share repurchases under two previously announced buyback programs totaling US$800 million and US$398.58 million. The combination of stronger earnings per share from continuing operations and meaningful reduction in shares outstanding underscores management’s focus on capital returns and earnings efficiency. With Unum’s recent...

Denali Therapeutics (DNLI) is back in focus after accelerated FDA approval of AVLAYAH, its first commercial product for neurologic Hunter syndrome in pediatric patients, with U.S. launch underway and initial payer discussions progressing. See our latest analysis for Denali Therapeutics. The AVLAYAH approval and pipeline updates come after a mixed share price pattern, with the stock up 20.59% year to date but longer term total shareholder returns still materially below earlier levels. This...

Ivanhoe Electric’s first-quarter 2026 results showed sales of US$858,000 and net income of US$41.74 million, a sharp turnaround from a net loss a year earlier, largely reflecting a very large gain from subsidiary Cordoba’s sale of the Alacrán copper-gold project. Alongside this profit swing, Ivanhoe Electric increased exploration spending at assets such as the Santa Cruz Copper Project and entered new copper-focused collaborations, including a partnership with SQM Chile, reshaping how...

In late April 2026, Sonoco Products Company filed a US$71.37 million shelf registration for 1,430,000 common shares tied to an ESOP-related offering. While the company recently reported strong earnings, the reliance on unusual items and flagged warning signs has raised questions about the quality and durability of its profit profile. We’ll now explore how the ESOP-related share issuance and questions over earnings quality intersect with Sonoco’s existing investment narrative. Uncover the...

AbCellera Biologics recently reported its first-quarter results, following earlier analyst forecasts for a year-over-year revenue increase and continued loss-making per share, alongside fresh insider share purchases. Together with upcoming presentations at major healthcare conferences, the insider buying hints at internal confidence as the company advances its antibody and clinical manufacturing ambitions. With insider buying as a backdrop, we’ll now examine how this earnings update could...

Stifel Financial (SF) has drawn fresh investor attention after launching a dedicated Project Finance platform focused on energy and infrastructure. The platform offers development and construction lending, risk management, and advisory services for projects with established credit profiles. See our latest analysis for Stifel Financial. Recent moves, including the Project Finance launch and fresh common and preferred dividend declarations, come after the share price has slipped around 10.6%...

Board changes, dividend and guidance reset the conversation around PROG Holdings stock PROG Holdings (PRG) has packed several investor focused signals into a short window, combining a leadership reshuffle, a declared cash dividend and updated full year guidance alongside its latest quarterly results. See our latest analysis for PROG Holdings. Those board changes, the fresh quarterly dividend and the raised 2026 guidance have come alongside a 23.6% 1 month share price return to $36.34 and a...

In early May 2026, BioLife Solutions reported first‑quarter 2026 results showing revenue of US$27.5 million versus US$22.05 million a year earlier, with net income improving to US$1.19 million from a net loss of US$0.448 million and earnings per share rising to US$0.02. The company also reiterated its 2026 outlook, pointing to ongoing demand for its biopreservation media franchise, mid‑60% gross margin expectations, and a shift to full‑year GAAP profitability supported by a cash balance of...

Maze Therapeutics: What Recent Returns Say About Investor Expectations Maze Therapeutics (MAZE) has drawn investor attention after a mixed stretch of stock performance, including a gain of about 2.2% over the past day alongside declines over the past week and month. See our latest analysis for Maze Therapeutics. The recent 1-day share price return of 2.2% comes after a sharp 90-day share price decline of 46.19%, while the 1-year total shareholder return of 156.96% highlights how sentiment has...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see A10 Networks...

Fast entry rule change sharpens focus on Nasdaq 100 Nasdaq (NDAQ) has updated its index rules so newly listed large caps can join the Nasdaq 100 after just 15 trading days, a material shift for investors tracking tech heavy benchmarks. See our latest analysis for Nasdaq. The fast entry rule change comes as Nasdaq’s share price sits at US$88.91, with a 30 day share price return of 6.91% and a year to date share price decline of 8.02%. Longer term total shareholder returns of 11.44% over one...

In April 2026, CTS Corporation reported first-quarter 2026 results showing higher sales of US$139.23 million and net income of US$17.2 million year on year, completed a US$18.28 million buyback of 405,242 shares announced in November 2025, and narrowed its 2026 sales guidance range to US$560 million–US$580 million. Management also highlighted plans to continue pursuing acquisitions to enhance diversification and earnings quality, signaling an ongoing focus on capital deployment beyond...